Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women (Q46115086)

19 December 2017

title

Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women (English)

1 reference

19 December 2017

0 references

2

Afschin Gandjour

1 reference

19 December 2017

author name string

Dirk Mueller

series ordinal

1

1 reference

19 December 2017

publication date

1 January 2008

1 reference

19 December 2017

Applied Health Economics and Health Policy

published in

1 reference

19 December 2017

volume

6

1 reference

19 December 2017

issue

2-3

1 reference

19 December 2017

page(s)

113-135

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/bf03256127

exact match

0 references

cites work

Can we detect women with low bone mass using clinical risk factors?

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Socioeconomic burden of hip fractures in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Clinical use of bone densitometry: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Relationship between bone quantitative ultrasound and fractures: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Combination of direct and indirect evidence in mixed treatment comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

A meta-analysis of previous fracture and subsequent fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Estimation of a common effect parameter from sparse follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Epidemiology of fractures in 15,000 adults: the influence of age and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

A systematic review of health state utility values for osteoporosis-related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

The risk and burden of vertebral fractures in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Using evaluations of diagnostic tests: understanding their limitations and making the most of available evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

How to read a paper. Papers that report diagnostic or screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Evaluating diagnostic tests with imperfect standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Bayesian cost-effectiveness analysis. An example using the GUSTO trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Costs, effects and C/E-ratios alongside a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Biases in the assessment of diagnostic tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Cost-effectiveness modeling research of pharmacologic therapy to prevent osteoporosis-related fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Assessment of fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

Guidelines for diagnosis and management of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

The Cost-Effectiveness of Bisphosphonates in Postmenopausal Women Based on Individual Long-Term Fracture Risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256127

21 January 2018

Identifiers

DOI

10.1007/BF03256127

1 reference

19 December 2017

1 reference

19 December 2017